Clinical Trial Update: Alisertib in Treating Patients With Advanced or Metastatic Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial update of alisertib in patients with advanced or metastatic soft tissue sarcomas, including myxofibrosarcoma and several histologies such as lei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Malignant Peripheral Nerve Sheath Tumor
• Myxofibrosarcoma
• Soft Tissue Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Myxofibrosarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-28